Centaurus Financial, Inc. Clearside Biomedical, Inc. Transaction History
Centaurus Financial, Inc.
- $1.37 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding CLSD
# of Institutions
56Shares Held
15.1MCall Options Held
22.7KPut Options Held
200-
Armistice Capital, LLC New York, NY3.96MShares$4.98 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.49MShares$3.14 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$2.77 Million3.43% of portfolio
-
Carmignac Gestion Paris, I02.13MShares$2.69 Million0.05% of portfolio
-
Black Rock Inc. New York, NY758KShares$955,3640.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $75.8M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...